Stock Research: Surgery Partners

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Surgery Partners

NasdaqGS:SGRY US86881A1007
23
  • Value
    65
  • Growth
    43
  • Safety
    Safety
    43
  • Combined
    42
  • Sentiment
    18
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Surgery Partners, Inc. is a healthcare services company operating a national network of surgical facilities and ancillary services. It primarily focuses on surgical facility services including ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities, and multi-specialty physician practices across various specialties like orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. The company operates in 31 states across the United States. In the last fiscal year, the company had 15000 employees, a market cap of $2846 million, profits of $835 million, and revenue of $3114 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock Surgery Partners are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Surgery Partners. The only rank that is above average is the consolidated Safety Rank at 65, which means that the company has a financing structure that is safer than those of 65% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 43, which means that the share price of Surgery Partners is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 43, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 18, which means that professional investors are more pessimistic about the stock than for 82% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
43 31 12 8
Growth
43 46 93 93
Safety
Safety
65 60 49 15
Sentiment
18 19 63 17
360° View
360° View
23 20 62 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
59 49 76 77
Opinions Change
6 50 50 50
Pro Holdings
n/a 7 65 13
Market Pulse
35 24 24 12
Sentiment
18 19 63 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
43 31 12 8
Growth
43 46 93 93
Safety Safety
65 60 49 15
Combined
42 42 52 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
51 22 17 1
Price vs. Earnings (P/E)
57 49 33 40
Price vs. Book (P/B)
67 51 50 16
Dividend Yield
1 1 1 1
Value
43 31 12 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
75 78 68 56
Profit Growth
23 20 100 79
Capital Growth
58 59 82 49
Stock Returns
17 27 67 93
Growth
43 46 93 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
35 41 40 26
Refinancing
90 75 59 42
Liquidity
36 32 43 31
Safety Safety
65 60 49 15

Similar Stocks

Discover high‑ranked alternatives to Surgery Partners and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.